fenofibrate has been researched along with dronedarone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Desai, NR; Dowd, B; Everhart, A; Herrin, J; Higuera, L; Jeffery, MM; Jena, AB; Karaca-Mandic, P; Ross, JS; Shah, ND; Smith, LB | 1 |
1 review(s) available for fenofibrate and dronedarone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fenofibrate and dronedarone
Article | Year |
---|---|
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Databases, Factual; Diabetes Mellitus, Type 2; Dronedarone; Evidence-Based Medicine; Female; Fenofibrate; Humans; Hypolipidemic Agents; Male; Medicare; Practice Patterns, Physicians'; Treatment Outcome; United States | 2020 |